NEPA as antiemetic prophylaxis after failure of 5HT3-RA plus dexamethasone in patients receiving carboplatin and gemcitabine chemotherapy: A monocentric real-life experience.

Maria Rosaria ValerioVittorio GebbiaNicolò BorsellinoMaria La VecchiaVincenzo SerrettaSalvatore PardoCalogero CipollaDaniele Galanti

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2020)

Our experience showed that NEPA has proven to be very effective and well tolerated in the prophylaxis of CINV induced by carboplatin-based chemotherapy.

Keyphrases

locally advanced
chemotherapy induced
phase ii study
rectal cancer
rheumatoid arthritis
squamous cell carcinoma
low dose
radiation therapy
clinical trial
randomized controlled trial
ankylosing spondylitis
systemic lupus erythematosus
systemic sclerosis